Crossmark

2-(2-Methoxyphenyl)-3-((Piperidin-1-yl)ethyl)thiazolidin-4-One-Loaded Polymeric Nanocapsules: In Vitro Antiglioma Activity and In Vivo Toxicity Evaluation

Crossref DOI link: https://doi.org/10.1007/s10571-019-00678-4

Published Online: 2019-05-21

Published Print: 2019-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

da Silveira, Elita Ferreira

Ferreira, Luana Mota

Gehrcke, Mailine

Cruz, Letícia

Pedra, Nathália Stark

Ramos, Priscila Treptow

Bona, Natália Pontes

Soares, Mayara Sandrielly Pereira

Rodrigues, Rodrigo

Spanevello, Rosélia Maria

Cunico, Wilson

Stefanello, Francieli M.

Azambuja, Juliana Hofstatter https://orcid.org/0000-0002-2416-7724
Horn, Ana Paula

Braganhol, Elizandra
License Information

Text and Data Mining valid from 2019-05-21

Version of Record valid from 2019-05-21
More Information

Article History

Received: 2 January 2019

Accepted: 16 April 2019

First Online: 21 May 2019

Compliance with Ethical Standards

:

: All the authors declares that they have no conflict of interest.

: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures used in the present study followed the Principles of Laboratory Animal Care from NIH and the Brazilian laws and were approved by the Ethical Committee of the Federal University of Pelotas (Protocol Number 9219).

Document is current

Any future updates will be listed below